3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
12
Neoplasms
7
Fatigue
6
Prostatic Neoplasms
5
Lung Neoplasms
5
Motor Activity
4
Lymphedema
4
Hematologic Neoplasms
4
Pain
3
Trismus
2
Peripheral Nervous System Diseases
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Glioma
2
Esophageal Neoplasms
2
Cachexia
2
Breast Neoplasms, Male
2
Urologic Neoplasms
1
Urinary Incontinence
1
Urinary Bladder Neoplasms
1
Transcranial Magnetic Stimulation, Repetitive
1
Thrombosis
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sleep Initiation and Maintenance Disorders
1
Shoulder Pain
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Interventions
Cyclophosphamide
409
Methotrexate
246
Cytarabine
231
Vincristine
188
fludarabine phosphate
172
Dexamethasone
169
fludarabine
143
Etoposide
143
Peripheral Blood Stem Cell Transplantation
136
Filgrastim
132
Whole-Body Irradiation
116
Mycophenolic Acid
115
Busulfan
112
Doxorubicin
109
Tacrolimus
106
Mercaptopurine
106
Cyclosporine
95
Radiotherapy
93
Melphalan
93
Rituximab
90
pegaspargase
88
Prednisone
85
Asparaginase
84
Daunorubicin
82
Granulocyte Colony-Stimulating Factor
74
blinatumomab
72
Antilymphocyte Serum
71
Calcium Dobesilate
69
Clofarabine
58
Thiotepa
55
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Physical Therapy Modalities
×
Clear all
NCT00902213
2015-11-17
PAQOL
St. Jude Children's Research Hospital
Phase NA
Completed
122 enrolled